ARAY Accuray Incorporated
Healthcare$0.37+0.00%OpenMarket Cap: $43.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.91
P/S
0.09
EV/EBITDA
-27.74
DCF Value
$1.78
FCF Yield
-79.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
26.8%
Operating Margin
-3.5%
Net Margin
-10.8%
ROE
-77.5%
ROA
-10.3%
ROIC
-5.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $104.8M | 24.1% | $-2.5M | $-11.8M | $— | — |
| Q2 null | $102.2M | 23.5% | $-5.5M | $-13.8M | $— | — |
| Q1 null | $93.9M | 28.3% | $-11.3M | $-21.7M | $— | — |
| Q4 null | $127.5M | 30.6% | $4.2M | $1.1M | $— | — |
| FY null | $458.5M | 32.1% | $7.8M | $-1.6M | $— | — |
| Q3 null | $113.2M | 27.9% | $1.0M | $-1.3M | $— | — |
| Q2 null | $116.2M | 36.1% | $4.7M | $2.5M | $— | — |
| Q1 null | $101.5M | 33.9% | $-2.1M | $-4.0M | $— | — |
| Q4 null | $134.3M | 28.6% | $6.8M | $3.4M | $— | — |
| FY null | $446.6M | 32.0% | $504.0K | $-15.5M | $— | — |
| Q3 null | $101.1M | 28.7% | $-4.6M | $-6.3M | $— | — |
| Q2 2024 | $107.2M | 33.5% | $-4.0M | $-9.6M | $-0.10 | — |